I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Flecainide acetate is used as a sodium channel blocker and as an anti-arrhythmic. In general, it is used to regulate heartbeats of the upper heart and lower heart chambers. It can also be used to slow down an overactive heart. It is also useful in the treatment of ventricular tachycardias and ventricular arrhythmias.
Doki, K.; Sekiguchi, Y.; Keisuke Kuga, K.; Aonuma, K.; Homma, M.Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity. Drug Metab. Pharmacokinet. 2015, 30 (4), 257-262.
Moffett, B. S.; Valdes, S. O.; Lupo, P. J.; delaUz, C.; Miyake, C.; Krenek, M.; Kim, J. J. Flecainide Use in Children with Cardiomyopathy or Structural Heart Disease. Pediatr. Cardiol. 2015, 36 (1), 146-150.
Hazard Statements: H302-H315-H319-H361-H335
Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. Suspected of damaging fertility or the unborn child. May cause respiratory irritation.
Precautionary Statements: P260-P201-P280g-P304+P340-P405-P501a
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.